

Struggling to find Citalopram at your pharmacy? Learn why this popular SSRI antidepressant can be hard to find in 2026 and what you can do about it.
You drop off your prescription for Citalopram, only to hear those dreaded words: "We don't have it in stock right now." If this has happened to you, take a deep breath — you're not the only one dealing with this frustration.
Citalopram (brand name Celexa) is one of the most commonly prescribed antidepressants in the United States. It belongs to a class of medications called selective serotonin reuptake inhibitors (SSRIs) and is primarily used to treat major depressive disorder. Millions of Americans rely on it every month, which is exactly why running into stock issues can feel so alarming.
Let's break down what's going on and what you can do about it.
Citalopram works by increasing the amount of serotonin available in your brain. Serotonin is a chemical messenger that plays a key role in regulating mood, sleep, and anxiety. By blocking its reabsorption, Citalopram helps keep serotonin levels higher, which can improve symptoms of depression over time.
Doctors prescribe Citalopram for its favorable side-effect profile, low cost, and effectiveness. It's available as a generic medication, which means it's accessible to most patients — typically costing between $10 and $20 per month with a discount coupon. It comes in 10 mg, 20 mg, and 40 mg tablets, as well as an oral solution.
Because it's so widely prescribed, even small disruptions in the supply chain can leave pharmacies temporarily out of stock.
The pharmaceutical supply chain is long and complex. Generic Citalopram is manufactured by several companies — including Teva, Aurobindo, Mylan, Lupin, and Torrent — but the raw materials often come from a small number of overseas suppliers. When there's a delay at any point in that chain, your local pharmacy may not get their shipment on time.
While Citalopram is not on the FDA's official drug shortage list as of early 2026, that doesn't mean every pharmacy has every strength on the shelf at all times.
Large chain pharmacies fill thousands of prescriptions per week. If a particular location sees a surge in demand for Citalopram — say, because a nearby clinic writes a lot of SSRI prescriptions — they can run out before their next delivery arrives. This is especially common at the beginning of the month when many patients refill at the same time.
You might find that your pharmacy has Citalopram 20 mg in stock but not the 40 mg tablets. Or they have tablets but not the oral solution. These formulation-specific shortages happen because pharmacies stock what they sell most. If you need a less common strength, you may need to check a few places.
Sometimes a pharmacy switches generic manufacturers based on contracts with their wholesaler. If the new manufacturer is backordered, the pharmacy may need to wait. This doesn't always show up as a "shortage" — it just means your specific pharmacy is between shipments.
The good news is that Citalopram is generally well-supplied and affordable. Here are steps you can take:
Stopping Citalopram suddenly can cause discontinuation symptoms including dizziness, irritability, nausea, and "brain zaps." If you're running low and can't find a refill, contact your prescriber as soon as possible. They may be able to call in a bridge prescription or suggest a temporary alternative.
For more detailed strategies, check out our guide on how to find Citalopram in stock near you.
Citalopram isn't experiencing a major national shortage — but that doesn't help much when your pharmacy is out of stock. The causes are usually temporary: supply chain hiccups, high local demand, or manufacturer transitions. The key is to be proactive, use tools like Medfinder, and stay in close contact with your pharmacist and prescriber.
Your mental health treatment shouldn't be interrupted by a logistics problem. With the right approach, you can find your medication and stay on track.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.